A Look At IDEXX Laboratories (IDXX) Valuation After Mixed Recent Share Price Performance

Simply Wall St.05-07

IDEXX Laboratories (IDXX) has drawn investor attention after recent share price moves, with the stock posting a modest one-month return alongside weaker performance over the past three months and year...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2633126077?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/29729-main-header/1756252961457","is_english":true,"pubTime":"2026-05-07 21:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2633126077","market":"hk","top_or_hot":-1,"title":"A Look At IDEXX Laboratories (IDXX) Valuation After Mixed Recent Share Price Performance","media":"Simply Wall St.","content":"<div>\n<p>IDEXX Laboratories (IDXX) has drawn investor attention after recent share price moves, with the stock posting a modest one-month return alongside weaker performance over the past three months and year...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/a-look-at-idexx-laboratories-idxx-valuation-after-mixed-rece-1\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At IDEXX Laboratories (IDXX) Valuation After Mixed Recent Share Price Performance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At IDEXX Laboratories (IDXX) Valuation After Mixed Recent Share Price Performance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-07 21:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/a-look-at-idexx-laboratories-idxx-valuation-after-mixed-rece-1><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>IDEXX Laboratories (IDXX) has drawn investor attention after recent share price moves, with the stock posting a modest one-month return alongside weaker performance over the past three months and year...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/a-look-at-idexx-laboratories-idxx-valuation-after-mixed-rece-1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1941712264.USD","symbol_name":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/a-look-at-idexx-laboratories-idxx-valuation-after-mixed-rece-1","article_id":"2633126077","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/29729-main-header/1756252961457"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/a-look-at-idexx-laboratories-idxx-valuation-after-mixed-rece-1","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2633126077","pubTimestamp":1778162181,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"IDEXX Laboratories (IDXX) has drawn investor attention after recent share price moves, with the stock posting a modest one-month return alongside weaker performance over the past three months and year to date.\nSee our latest analysis for IDEXX Laboratories.\nRecent moves have been mixed, with a 2.89% 1 day share price gain and 4.62% 7 day share price return sitting against a 10% 90 day share price decline and 13.55% year to date share price decline. At the same time, the 1 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4567":"ESG概念","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","IDXX":"爱德士实验室","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU0345774391.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) ACC","BK4082":"医疗保健设备","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","BK4504":"桥水持仓","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","BK4588":"碎股","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU1941712348.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"AT\" (USD) ACC"},"translate_title":"近期股价表现好坏参半后看看IDEXX Laboratories(IDXX)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IDXX":1.5},"content_text":"IDEXX Laboratories (IDXX) has drawn investor attention after recent share price moves, with the stock posting a modest one-month return alongside weaker performance over the past three months and year to date. See our latest analysis for IDEXX Laboratories. Recent moves have been mixed, with a 2.89% 1 day share price gain and 4.62% 7 day share price return sitting against a 10% 90 day share price decline and 13.55% year to date share price decline. At the same time, the 1 year total shareholder return of 19.03% and 3 year total shareholder return of 19.40% point to momentum that has been stronger over longer periods than in the most recent quarter. If you are weighing IDEXX alongside other opportunities in healthcare technology, it can be useful to scan a broader set of companies using our screener focused on 32 healthcare AI stocks With IDEXX Laboratories posting mixed recent returns yet carrying an intrinsic value estimate slightly above its current share price, the key question is whether you are seeing a genuine opening here or whether the market already prices in future growth. AdvertisementMost Popular Narrative: 23% Undervalued The most followed narrative sees IDEXX Laboratories trading below its fair value estimate of $750.23, with the last close at $579.23, and ties that gap to recurring diagnostics growth, margins and premium pricing.  Rapid adoption of innovative diagnostic platforms such as inVue Dx, Catalyst Cortisol, and Cancer Dx are expanding IDEXX's addressable market and boosting recurring consumables demand, which is likely to drive sustained revenue and margin growth as new product usage ramps and menu breadth increases.  Read the complete narrative. Curious what kind of revenue growth, margin profile and future earnings multiple need to hold together for that fair value to make sense? The narrative leans on firmly defined top line expectations, a step up in profitability and a premium P/E that sits well above the broader medical equipment group. The full story joins those moving parts into one valuation puzzle. Result: Fair Value of $750.23 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, softer U.S. clinical visit trends and pressure on pricing power, especially if large veterinary groups push back on increases, could challenge the growth and margin story that investors are leaning on. Find out about the key risks to this IDEXX Laboratories narrative. Another Way To Look At Valuation While the narrative suggests a fair value of $750.23 based on future earnings and growth assumptions, the current P/E of 42x looks high compared with the US Medical Equipment industry at 23.6x, a peer average of 25.7x and a fair ratio of 29.3x. This points to valuation risk if sentiment cools. For a closer look at how this price compares with earnings power, and what the P/E gap could imply if the market moves toward the fair ratio, check the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown. NasdaqGS:IDXX P/E Ratio as at May 2026Next Steps Seeing both upside potential and clear risks in this story, it makes sense to move quickly and review the data for yourself so your view is grounded in the full picture, including the 3 key rewards and 2 important warning signs. Looking for more investment ideas? If IDEXX has caught your eye, do not stop here. The best opportunities often appear when you compare a few strong but very different stocks side by side.  Target resilient growth by scanning companies on the 44 high quality undervalued stocks that pair quality fundamentals with pricing that may look more attractive than market favorites. Prioritize peace of mind by reviewing the 74 resilient stocks with low risk scores to see stocks that score well on balance sheet strength and risk factors. Hunt for potential future leaders before they are widely followed by using the screener containing 23 high quality undiscovered gems to spot stocks with quality metrics that many investors may overlook.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2633126077","isCrawlerRequest":true}